Elsevier

Biochemical Pharmacology

Volume 53, Issue 11, 1 June 1997, Pages 1649-1657
Biochemical Pharmacology

Research paper
Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: A comparison with tyrosine kinase and protein kinase C inhibition

https://doi.org/10.1016/S0006-2952(97)82453-7Get rights and content

Abstract

Depending on their structure, flavonoids display more or less potent inhibitory effects on the growth and proliferation of certain malignant cells in vitro, and these effects are thought to be due to inhibition of various enzymes. We investigated the inhibitory action of fourteen flavonoids of different chemical classes on phosphatidylinositol 3-kinase a (PI 3-kinase a) activity, an enzyme recently shown to play an important role in signal transduction and cell transformation. Of the fourteen flavonoids tested, myricetin was the most potent PI 3-kinase inhibitor (ic50 = 1.8 μM), while luteolin and apigenin were also effective inhibitors, with ic50 values of 8 and 12 μM, respectively. Fisetin and quercetin, as previously reported, were also found to significantly inhibit PI 3-kinase activity. The same flavonoids were also analyzed for inhibition of epidermal growth factor receptor (EGF-R), intrinsic tyrosine kinase and bovine brain protein kinase C (PKC). At elevated doses, some of these flavonoids were found to also cause significant inhibition of PKC and tyrosine kinase activity of EGF-R. A structure-activity study indicated that the position, number and substitution of the hydroxyl group of the B ring, and saturation of the C2C3 bond are important factors affecting flavonoid inhibition of PI 3-kinase. They may also play a significant role in specificity of inhibition and could help to provide a basis for the further design of specific inhibitors of this lipid kinase. Finally, possible relationships between the antitumoral properties of these flavonoids and their biological activities are discussed.

References (38)

  • T Akiyama et al.

    Genistein, a specific inhibitor of tyrosine-specific protein kinase

    J Biol Chem

    (1987)
  • JFM Post et al.

    Growth inhibitory effects of bioflavonoids and related compounds on human leukemic CEM-C1 and CEM-C7 cells

    Cancer Lett

    (1992)
  • M Yoshida et al.

    The effect of quercetin on cell cycle progression and growth of human gastric cancer cells

    FEBS Lett

    (1990)
  • K Katagiri et al.

    Modulation of monocytic differentiation of HL 60 cells by inhibitors of protein tyrosine kinase

    Cell Immunol

    (1992)
  • J Levy et al.

    Biochem Biophys Res Commun

    Biochem Biophys Res

    (1984)
  • E Middleton et al.

    The impact of plant flavonoids on mammalian biology: Implications for immunity, inflammation and cancer

  • RL Geahlen et al.

    Inhibition of protein kinase C activity by flavonoids and related compounds

    J Nat Products

    (1989)
  • M Cushman et al.

    Synthesis and protein-tyrosine kinase inhibitory activities of flavonoid analogues

    J Med Chem

    (1991)
  • R Kapeller et al.

    Phosphatidylinositol 3-kinase

    BioEssays

    (1994)
  • Cited by (528)

    • Nano-based phytodrug delivery systems for the management of neurodegenerative disorders

      2022, Nanomedical Drug Delivery for Neurodegenerative Diseases
    • Antimetastatic effects of VOflavonoid complexes on A549 cell line

      2021, Journal of Trace Elements in Medicine and Biology
    View all citing articles on Scopus
    View full text